Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19231-06-2

Post Buying Request

19231-06-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19231-06-2 Usage

Chemical Properties

White Solid

Uses

Different sources of media describe the Uses of 19231-06-2 differently. You can refer to the following data:
1. bis(p-methoxyphenyl)iodonium bromide is a diphenyliodonium compound. In vitro fermentation studies have showed that diphenyliodonium compounds are inhibitors of amino acid utilization. Di(p-anisyl)iodonium Br omide is used as a reactant in the preparation of Thyroid hormone analogs and analogs of clofibrate and clobuzarit.
2. Di(p-anisyl)iodonium Bromide is a diphenyliodonium compound. In vitro fermentation studies have showed that diphenyliodonium compounds are inhibitors of amino acid utilization. Di(p-anisyl)iodonium Bromide is used as a reactant in the preparation of Thyroid hormone analogs and analogs of clofibrate and clobuzarit.

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 19231-06-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,2,3 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 19231-06:
(7*1)+(6*9)+(5*2)+(4*3)+(3*1)+(2*0)+(1*6)=92
92 % 10 = 2
So 19231-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C14H14IO2.BrH/c1-16-13-7-3-11(4-8-13)15-12-5-9-14(17-2)10-6-12;/h3-10H,1-2H3;1H/q+1;/p-1

19231-06-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name bis(4-methoxyphenyl)iodanium,bromide

1.2 Other means of identification

Product number -
Other names bis(4-methoxyphenyl)iodanium bromide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19231-06-2 SDS

19231-06-2Relevant articles and documents

-

Azoo,J.A. et al.

, p. 2521 - 2522 (1969)

-

Thyroid Hormone Analogues. Synthesis of 3'-Substituted 3,5-Diiodo-L-thyronines and Quantitative Structure-Activity Studies of in Vivo Thyromimetic Activities in Rat Liver and Heart

Leeson, Paul D.,Ellis, David,Emmett, John C.,Shah, Virendra P.,Showell, Graham A.,Underwood, Anthony H.

, p. 37 - 54 (2007/10/02)

Twenty-nine 3'-substituted derivatives of the thyroid hormone 3,3',5-triiodo-L-thyronine (T3) have been synthesized by using established methods and by new route involving manipulation of a 3'-formyl intermediate.In vitro hormone receptor binding (to intact nuclei) and in vivo thyromimetic activity (induction of mitochondrial 3-phosphoglycerate oxidoreductase, GPDH) were measured in rat liver and heart for these new analogues and for the 18 previously reported 3'-substituted 3,5-diiodo-L-thyronines.Analysis of the binding data using theoretical conformational and quantitative structure-affinity methods implies that the 3'-substituent recognition site on the thyroid hormone receptor is hydrophobic and limited in depth to the length of the natural iodo substituent, but has sufficient width to accomodate a phenyl or cyclohexyl group.Receptor binding is reduced by approximately 10-fold in 3'-acyl derivatives which form strong intramolecular acceptor hydrogen bonds with the ajacent 4'-hydroxyl.The compounds studied showed no differences in their relative affinities for heart and liver nuclei, suggesting that receptors in these tissues are similar.However, the relationships between thyromimetic activity (induction of GPDH) and nuclear binding showed some tissue differences.A high correlation between activity and binding is observed for full agonists in the heart, but an equally significant correlation for the liver data is only seen when 3'-substituent bulk (molar reactivity) is included in the analysis.These results suggest the possibility that differential tissue penetration or access to receptors may occur in vivo.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19231-06-2